] . (2011). DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials. Lancet Infect Dis, 11(12), 916-24. presented at the 2011 Dec. doi:10.1016/S1473-3099(11)70240-7
. (2013). Prime-boost interval matters: a randomized phase 1 study to identify the minimum interval necessary to observe the H5 DNA influenza vaccine priming effect. J Infect Dis, 208(3), 418-22. presented at the 2013 Aug 01. doi:10.1093/infdis/jit180